Prospective Coronary Heart Disease Cohort

NCT05699629 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2023-02-13

No results posted yet for this study

Summary

To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.

Conditions

Sponsors & Collaborators

  • Jinan Central Hospital

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • The Second Affiliated Hospital of Shandong First Medical University

    collaborator OTHER
  • Qianfoshan Hospital

    collaborator OTHER
  • Shandong First Medical University

    lead OTHER

Principal Investigators

  • Tao Xu, Dr. · Shandong First Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-21
Primary Completion
2027-01-21
Completion
2027-01-21

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05699629 on ClinicalTrials.gov